Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Prothena Corp
PRTA
$441M
| $74M | 0.04% |
2,035,984
+209,375
| +11% | +$8.06M |
|
302
Hartford Financial Services
HIG
$39.9B
| $73.4M | 0.04% |
913,556
-7,508
| -0.8% | -$565K |
|
303
HealthEquity
HQY
$8.67B
| $72.2M | 0.04% |
1,088,267
+899
| +0.1% | +$62.3K |
|
304
Sabra Healthcare REIT
SBRA
$5.56B
| $72.1M | 0.04% |
5,054,134
+760,657
| +18% | +$10.8M |
|
305
Neogen
NEOG
$2B
| $72M | 0.04% |
3,581,946
+257,670
| +8% | +$4.36M |
|
306
PTC Therapeutics
PTCT
$6.17B
| $72M | 0.04% |
2,612,593
-459,727
| -15% | -$10.5M |
|
307
Brown-Forman Class B
BF.B
$13.5B
| $71.7M | 0.04% |
1,256,177
+315,245
| +34% | +$18.1M |
|
308
Innospec
IOSP
$2.11B
| $71.6M | 0.04% |
581,053
+916
| +0.2% | +$97.5K |
|
309
DexCom
DXCM
$29.2B
| $71.3M | 0.04% |
574,517
-886,978
| -61% | -$90.6M |
|
310
Conagra Brands
CAG
$7.44B
| $71.1M | 0.04% |
2,479,853
-16,595
| -0.7% | -$465K |
|
311
American Homes 4 Rent
AMH
$12.1B
| $69.7M | 0.04% |
1,937,343
+1,848,337
| +2,077% | +$64.5M |
|
312
Baxter International
BAX
$12.7B
| $69.4M | 0.04% |
1,794,361
-96,523
| -5% | -$3.41M |
|
313
GATX Corp
GATX
$6.45B
| $69.2M | 0.04% |
575,689
+200,055
| +53% | +$22.1M |
|
314
Waste Management
WM
$95.7B
| $68.5M | 0.04% |
382,244
+114,308
| +43% | +$19.2M |
|
315
Parker-Hannifin
PH
$120B
| $68.3M | 0.04% |
148,286
-21,754
| -13% | -$9.06M |
|
316
Kirby Corp
KEX
$7.11B
| $67.9M | 0.04% |
865,001
+216,472
| +33% | +$16.9M |
|
317
NNN REIT
NNN
$9.33B
| $67.5M | 0.04% |
1,565,211
-451,348
| -22% | -$17.5M |
|
318
ATS Corp
ATS
$2.59B
| $67.1M | 0.04% |
1,548,566
+4,754
| +0.3% | +$184K |
|
319
Stride
LRN
$4.14B
| $66.7M | 0.04% |
1,124,141
-73,882
| -6% | -$4.04M |
|
320
AGCO
AGCO
$8.42B
| $66.6M | 0.04% |
548,314
-78,396
| -13% | -$9.17M |
|
321
Ameris Bancorp
ABCB
$5.88B
| $66.5M | 0.04% |
1,253,720
-51
| -0% | -$2.18K |
|
322
Brixmor Property Group
BRX
$9.79B
| $66.3M | 0.04% |
2,846,666
-557,178
| -16% | -$12M |
|
323
CDW
CDW
$18.9B
| $66M | 0.04% |
290,096
+36,031
| +14% | +$7.64M |
|
|
ENV
324
DELISTED
ENVESTNET, INC.
ENV
| $65.4M | 0.04% |
1,321,481
-143,753
| -10% | -$5.88M |
|
|
WNS
325
DELISTED
WNS Holdings
WNS
| $65M | 0.04% |
1,027,744
-37,919
| -4% | -$2.32M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.